Prosteks 0.03g rectal suppositories 10s

The instruction for medical use of PROSTEKS medicine the Trade name of PROSTEKS the International unlicensed name Is not present the Dosage form Suppositories rectal on 0.03 g Structure One suppository contains active agent - a prostatilen of 0.03 g excipients: polysorbate 80 0.00025 of oil of seeds of pumpkin of 0.5 g the water purified, solid fat enough for receiving a suppository weighing 2.5 g the Description Suppositories from light yellow with a greenish shade till the color, green with a yellowish shade. Marbling of coloring is allowed. Pharmacotherapeutic group Drugs for treatment of urological diseases. Other drugs for treatment of urological diseases. The ATX G04BX code the Pharmacological Pharmacokinetics Components properties of drug are effectively soaked up from a rectum. Prostex it is split by cellular proteases to amino acids, it does not kumulirutsya. Prostex and its metabolites are excreted with urine. A pharmacodynamics Drug is used for treatment of diseases of a prostate. Prostex which is a part of suppositories, has organotropic effect on a prostate (prostatoprotektorny effect), anti-inflammatory action, reducing hypostasis and leukocytic infiltration of gland, improves processes of a mirotsirkulyation and a platelet and vascular hemostasis, positively affects functional activity of spermatozoa. Stimulates activity of a humoral link of immunity and some factors of resistance of an organism, influences a tone of muscles of a bladder, including a detruzor tone. Indications - chronic prostatitis - prevention and treatment of complications after operations on a prostate the Route of administration and Rektalno's doses. The suppository is exempted from packing and entered deeply into an anus. Use on 1 suppository 1-2 times a day (in the morning and in the evening) within 5-10 days. Duration of a course is defined by the character and disease severity reached by therapeutic effect, the nature of therapy (monotherapy or complex treatment). If necessary the course can be repeated in 1-6 months. Side effects Allergic reactions: itching, dermahemia, skin rashes, changes in the injection site: the burning sensation in case of allergic reactions treatment is stopped, it is recommended to see behind consultation the attending physician. Contraindications - the hypersensitivity to drug components, in particular to proteins of cattle - children's and teenage age up to 18 years Medicinal interactions Medicinal interaction with the drug Prostex was not studied Special instructions With care to appoint in atherosclerosis, the increased risk of developing a thrombembolia. At long-term use of high doses of drug it is necessary to control a blood clotting time. At drug treatment it is recommended to carry out the analysis of clinical indicators of activity of a prostate (prostatospetsifichny antigen). Drug is almost free from sodium and potassium. After use of suppositories it is necessary to wash up hands carefully. Drug is not used by women. Features of influence of medicine on ability to run the vehicle or potentially dangerous mechanisms. Data are absent. Overdose Cases of overdose are not described. A form of release and packing On 5 suppositories in blister strip packaging from a film polyvinylchloride. Two blister strip packagings together with the instruction for medical use in the state and Russian languages put in a pack from cardboard bandbox (chrome ersatz). To Store storage conditions in original packing for protection against influence of light at a temperature from 2 wasps up to 8 wasps. To store out of children's reach! 3 years not to use a period of storage after a period of storage. Prescription status Without prescription the Producer/packer of LLC Federal Law BIOFARMA, Ukraine 09100, Kiev Region, Bila Tserkva, Kiyevskaya St., 37 of ph. (044) 277-36-10 The holder of the registration certificate of LLC Federal Law BIOFARMA, Ukraine the Address of the organization accepting in the territory of the Republic of Kazakhstan claims from consumers on quality of the products (goods) responsible for post-registration observation of safety of medicine Representative office of LLC Federal Law BIOFARMA in RKg. Almaty, Miras 65, BC Miras, office 101